Dr. Timothy Volmer Tells All

Timothy Vollmer, M.D. is an associate professor of neurology, and the director of the Yale Neuroimmunology Program. He's also the director of the NARCOMS registry.

Dr. Vollmer spoke in depth of his current involvement in the advances made in the treatment of MS. He displayed an uncommon ability to articulate an evolving biotechnology focused on MS. As he spoke, one could observe the analytical manner in which a solution is evolving through his all-telling account of failures as well as successes.

In recent years the Yale Neuroimmunology Program
has been sponsored by Teva to conduct clinical trials
of their product, Copaxone. Dr. Vollmer explained why he
thought Copaxone was the next generation MS treatment.

Return To Boa '97 Index Page"


_______________________________

NARCOMS
North American Research Consortium on MS


P.O. Box 208018 Timothy L. Vollmer, M.D.
Director
Olympia Hadjimichael, M.P.H.
Coordinator, NARCOMS
Registry
New Haven, CT 06520
1-800-253-7884
(203) 785-5694 Fax
olympia.hadjimichael@yale.edu

April 16, 1997

Susan Jaremsek
C/O Rowley Corvette Supply, Inc.
357 Main St.
Rowley, MA 01969

Dear Susan,

Thank you for your interest in the NARCOMS Registry. NARCOMS is a national multi-
center research program committed to accelerating the development of better treatment
options and health care services for individuals with multiple sclerosis. Your participation
will help make our efforts successful.

Be assured that the NARCOMS MS Patient Registry:
ThePatient Registry is NOT:
Please return your completed registry in the enclosed stamped and self-addressed envelope. If
you have any questions, please feel free to call me.

Sincerely,

Olympia Hadjimichael, M.P.H.
Coordinator, NARCOMS Registry